In the present study, we found that hypoxia or CoCl 2 enhanced the mRNA expression of DEC2, as well as DEC1, within 24 h in chondrogenic ATDC5, 293T, and HeLa cells. In luciferase assays, the regions between ؊524 and ؊401 in the DEC1 promoter, and between ؊863 and ؊258 in the DEC2 promoter, were responsible for the hypoxia-or hypoxiainducible factor-1␣ (HIF-1␣)-induced transcription. In these regions, we identified functional hypoxia response elements (HREs) that bound to HIF-1␣ and HIF-1. In addition to an HIF-1 binding site consensus sequence, the DEC1 HRE had cAMP response element-like and CACAG sequences, which were also involved in the transcription activation in response to HIF-1␣. Although the DEC2 HRE did not have a cAMP response element-like or CACAG sequence, it showed a higher affinity for HIF-1 than did the DEC1 HRE. Because DEC1 and DEC2 are directly inducible by HIF-1, these transcription factors may be crucial for the adaptation to hypoxia.Recently we cloned the cDNA for the novel basic helix-loophelix (bHLH) 1 transcription factor DEC1 (BHLHB2), which was expressed at a higher level in human primary chondrocytes than in fibroblastic cells (1). A mouse ortholog (Stra13) and a rat ortholog (SHARP-2) of DEC1 were identified independently by others in the P19 embryonal carcinoma cells and rat brain, respectively (2, 3), and the mRNA of DEC1 was found in a variety of embryonic and adult tissues (1-3). In addition, we cloned a member of the DEC subfamily of bHLH proteins, DEC2 (BHLHB3), by searching the expressed sequence tags data bank (4). DEC2 is similar to SHARP-1 (3), which is a truncated molecule of DEC2 produced by a sequencing error or a minor frameshift mutant (4). The bHLH regions of DEC1 and DEC2 exhibit the highest similarities to those of Drosophila Hairy, Enhancer of split and mammal HES, which are known as transcriptional repressors with the WRPW motif, which interacts with the Groucho family members of corepressors. Although the Stra13/DEC1 and DEC2/SHARP-1 lack the WRPW motif, they also act as transcriptional repressors by a discrete mechanism (5, 6). Stra13/DEC1 interacts physically with the components of the basal transcription machineries, such as TATA-binding protein and TFIIB, and can recruit the histone deacetylase 1-Sin3A-NcoR corepressor complex through their carboxyl-terminal repression domain (5).DEC1/Stra13/SHARP-2 may be involved in the control of the proliferation and/or differentiation of chondrocytes, nerve cells, fibroblasts, and T cells (1-3, 7). The overexpression of DEC1/ Stra13 promoted a chondrogenic differentiation of the mesenchymal stem cells, 2 and a neural differentiation of the P19 cells (2). Recently, Stra13-deficient mice were generated, and it was shown that Stra13/DEC1 is a key regulator of lymphocyte activation that is vital for the maintenance of self-tolerance and constraint of autoimmunity. Other phenotypic differences between Stra13 Ϫ/Ϫ mutants and the wild-type littermates have not been reported (7). On the other hand, DEC2/SHARP-1 worked as a tran...